semaglutide illegal FDA Drug Recalls and Warnings: GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA warns consumers not to

What Studies Show About Muscle Loss on GLP-1 Drugs The evidence on lean mass loss during GLP-1 therapy comes from the same large clinical trials that established these drugs as effective for weight loss

This means that as we age, our bodies become less efficient at absorbing B12, making deficiency more common among the elderly

the needles on the injection pens are so thin and short that they wont go very deep

Monitoring your health while using a GLP-1 receptor agonist is important, and certain symptoms or situations, such as the ones below, should prompt a consultation with a doctor: New or worsening gastrointestinal symptoms, such as persistent nausea, vomiting, diarrhoea, or signs of dehydration 7 , 27

Personalized advice is crucial, especially for individuals managing chronic conditions